net dbt
sale maintain above-street ep
quarter ahead expect
pg report ahead expect organ sale y/i vs bofaml
ep vs bofaml/street sale op profit vs
outlook elabor first take note key take-away
pg result outpac peer strong reason believ sustain ahead
see number posit develop suggest momentum sustain even
known risk china growth acceler vs month
india e-commerc end sustain
growth top country-categori combin held grew
share vs management note consumpt
share progress nice categori growth improv broadli pg
note recent develop occur develop develop market
growth vs prior price expect stronger driver action
mostli effect fulli implement vs pg note seen anyth
suggest high level concern success price increas rather note
potenti volum impact price move high high
inflat argentina turkey difficult predict importantli cfo moeller note
solid first half year clean perspect retail inventori vs
consumpt reason pg maintain low-end organ sale guid
vs prior function caution around competit
dynam rather anyth see busi date
see flexibl hit target reiter buy po
pg fundament acceler flexibl hit exceed target given org
sale track ahead fy guidanc vs guid ep ytd
acceler comp rel unchang sale vs easier
margin op margin vs guid embed advers competit
activity/consum respons shown result rais fy org sale
estimate slightli maintain street-high ep estimate y/i vs guid
full definit iqmethod sm measur see page
bofa merril lynch seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price object
basis/risk page
return capit employ
return equiti
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
procter gambl pg one world largest
consum product compani oper five
babi famili
ariel alway tampax downi dawn
 industri bellweth consum
stapl industri owe diversifi product
portfolio multi-billion brand lead global
share posit result challeng
time recent initi around compani
focus portfolio bear fruit
see potenti sustain top-lin beat
rais quarter ahead
pg report ep vs bofaml/street organ sale growth
y/i ahead bofaml
divis organ sale better expect beauti vs bofaml
health vs fabric vs babi feminin
famili vs groom vs flat
gross margin declin y/i vs bofaml/street
oper margin y/i vs bofaml/street oper profit
dollar forecast
tabl pg y/i perform segment categori
note organ volum price mix may add total organ sale due round
dm flat due competit activ
em driven premium innov price retail execut
em led strong growth china olay skin sk-ii
person
dm led doubl digit sk-ii growth japan premium product innov skin
dm follow strong merchandis support heighten competit activ
dm growth power toothbrush premium toothpast innov price
em price inflat strong retail execut
em price strong result past latam
overal innov driven volum gain price increas across market
dm volum driven innov across laundri fabric enhanc increment
em driven premium innov price inflat
overal led growth across segment strength driven innov driven
volum superior retail execut includ enhanc merchandis program
dm driven soft mid-tier valu tier diaper volum reduct
em driven strong growth pant form premium tape diaper price
overal led growth premium innov favor product mix alway
overal led innov driven volum price increas distribut
guidanc sale product target rais
complet pg rais outlook organ sale high end vs
prior all-in sale expect improv vs prior
flat predic improv organ sale unchang outlook fx
ep expect remain y/i impli improv sale
outlook expect fx commod transport cost tax
aggreg vs prior
fx sale
interest expense/incom non-oper incom
fx commod transport after-tax incom
chang
chang
chang
chang
chang
chang
ep growth
flat
good sold report
good sold
sale
sale
good sold report
good sold
sale
sale
sale
depreci amort
ep charg dilut
price object base ep estim vs target
large-cap hpc group pg taken number action turn around result
view bear fruit top-lin momentum resum
potenti margin also see benefit strength sustain inflat eas
longer term continu see pg scale differenti innov portfolio
brand strength key advantag
upsid price object faster expect sale growth improv visibl
sustain ahead equiti market turn defens caus pg
defens qualiti rel attract downsid risk price object
slow recent sale momentum advers competit respons name
privat label come month pg look institut price increas return
risk-on would make pg defens qualiti less attract
olivia tong cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
helen troy
qualiti earn
iqmethod smi set bofa merril lynch standard measur serv maintain global consist three broad head busi perform qualiti earn valid key featur
iqmethod consist structur detail transpar methodolog guidelin maxim effect compar valuat process identifi common pitfal
iqdatabas real-tim global research databas sourc directli equiti analyst earn model includ forecast well histor data incom statement balanc sheet cash
flow statement compani cover bofa merril lynch
iqprofil sm iqmethod sm servic mark america corpor iqdatabas regist servic mark america corpor
